Alkegen files prepackaged Chapter 11 after securing deal to eliminate $3.1bn of debt

October 2026 | DEALFRONT | BANKRUPTCY & CORPORATE RESTRUCTURING

Financier Worldwide Magazine

October 2026 Issue

Specialty materials manufacturer Alkegen has entered a restructuring support agreement (RSA) with its lenders and subsequently filed a prepackaged Chapter 11 bankruptcy case aimed at reducing its debt burden, strengthening its balance sheet and supporting future growth.

The Clearlake Capital-backed company has secured approximately $315m in new financing to support operations throughout the restructuring process and expects to eliminate around $3.1bn of debt. Following completion of the restructuring, Alkegen anticipates emerging with about $200m in available liquidity and a substantially improved capital structure.

According to the company, the transaction will provide greater financial flexibility and support long-term investment plans. Alkegen said approximately $70m of capital improvements are already under way during 2026, with a further $300m of investment expected by 2030.

The agreement followed discussions with the company’s principal financial stakeholders and received overwhelming support from key lender groups. Alkegen said the arrangement reflects investor confidence in its operations, product portfolio and long-term prospects. Once the restructuring is completed, ownership of the business is expected to transfer to a group of institutional investors.

After announcing the RSA, Alkegen formally commenced prepackaged Chapter 11 proceedings in the US Bankruptcy Court for the Northern District of Texas. The company launched a solicitation process before the filing to secure votes on its proposed plan of reorganisation and entered the court process with significant creditor backing already in place.

Management has stressed that customers, suppliers, employees and other stakeholders should experience minimal disruption while the restructuring proceeds. Manufacturing and commercial operations are continuing as normal and the company expects to maintain existing relationships across its global network.

Alkegen has also stated that trade creditors, vendors and suppliers will remain unaffected by the process. Holders of non-debt general unsecured claims are expected to be unimpaired under the proposed restructuring plan, allowing the company to continue meeting its obligations in the ordinary course of business.

“Today’s announcement marks an important step in strengthening Alkegen’s financial foundation for the future,” said Brian Whittman, chief executive of Alkegen. “This agreement has the overwhelming support of our financial partners, underscoring their confidence in our business and the critical role we play in the specialty materials industry.

“With a substantially stronger balance sheet and greater financial flexibility, Alkegen will be well-positioned to invest in innovation, support our customers, and execute ongoing strategic initiatives that will drive future growth,” he continued. “We are grateful to our employees for their continued dedication and to our customers, suppliers, and partners for their ongoing support.”

Alkegen manufactures engineered materials used in a wide range of industrial and commercial applications, including refractory ceramic fibre, polycrystalline wool, aerogel composites and micro-fine glass products. These materials are used in thermal insulation, fire protection, filtration and battery safety systems serving sectors such as steel and aluminium production, petrochemical refining, automotive emissions control, electric vehicles, aerospace and commercial construction.

The company employs approximately 3900 people across 23 countries and operates around 50 integrated manufacturing facilities worldwide.

Given Alkegen’s position within specialist materials markets, the restructuring is being closely watched across the manufacturing sector. The company supplies products that support temperature management, filtration and energy-transition applications relied upon by a broad range of industries. Its technologies are also used in demanding environments where performance, safety and regulatory compliance are critical considerations for customers across multiple industrial sectors worldwide.

Although the restructuring is primarily financial rather than operational, any disruption to a supplier of Alkegen’s scale could have implications for manufacturers operating complex global supply chains. The company, however, has repeatedly stated that operations are expected to continue without interruption throughout the court-supervised process.

The restructuring aims to secure Alkegen’s future while maintaining operational stability and customer confidence.

Richard Summerfield